Bridger Management as of June 30, 2015
Portfolio Holdings for Bridger Management
Bridger Management holds 44 positions in its portfolio as reported in the June 2015 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY) | 45.6 | $1.4B | 7.0M | 205.85 | |
Post Holdings Inc Common (POST) | 2.8 | $90M | 1.7M | 53.93 | |
Laboratory Corp Amer Hldgs Com New | 2.5 | $79M | 650k | 121.22 | |
Alnylam Pharmaceuticals (ALNY) | 2.4 | $75M | 624k | 119.87 | |
Hca Holdings (HCA) | 2.3 | $73M | 799k | 90.72 | |
Medicines Company | 2.3 | $71M | 2.5M | 28.61 | |
Cardinal Health (CAH) | 2.1 | $65M | 780k | 83.65 | |
Allergan SHS | 2.0 | $63M | 207k | 303.46 | |
Boise Cascade (BCC) | 1.9 | $62M | 1.7M | 36.68 | |
Marathon Petroleum Corp (MPC) | 1.9 | $60M | 1.1M | 52.31 | |
UnitedHealth (UNH) | 1.8 | $57M | 470k | 122.00 | |
Assured Guaranty (AGO) | 1.8 | $56M | 2.4M | 23.99 | |
Scientific Games Corp Cl A (LNW) | 1.8 | $56M | 3.6M | 15.54 | |
Insulet Corporation (PODD) | 1.8 | $56M | 1.8M | 30.99 | |
KAR Auction Services (KAR) | 1.7 | $55M | 1.5M | 37.40 | |
CIGNA Corporation | 1.7 | $55M | 336k | 162.00 | |
Zoetis Cl A (ZTS) | 1.7 | $54M | 1.1M | 48.22 | |
Facebook Cl A (META) | 1.6 | $49M | 575k | 85.77 | |
Kythera Biopharmaceuticals I | 1.5 | $48M | 641k | 75.31 | |
Mallinckrodt Pub SHS | 1.5 | $47M | 400k | 117.72 | |
EXACT Sciences Corporation (EXAS) | 1.4 | $46M | 1.5M | 29.74 | |
Charter Communications Inc D Cl A New | 1.4 | $44M | 254k | 171.25 | |
Verisign (VRSN) | 1.2 | $38M | 616k | 61.72 | |
WellCare Health Plans | 1.1 | $35M | 409k | 84.83 | |
MGM Resorts International. (MGM) | 1.1 | $33M | 1.8M | 18.25 | |
Pennymac Finl Svcs Cl A | 1.0 | $33M | 1.8M | 18.12 | |
Humana (HUM) | 1.0 | $32M | 169k | 191.28 | |
Trovagene Com New | 1.0 | $32M | 3.2M | 10.15 | |
Ironwood Pharmaceuticals Com Cl A (IRWD) | 1.0 | $30M | 2.5M | 12.06 | |
Centene Corporation (CNC) | 0.9 | $30M | 372k | 80.40 | |
Eli Lilly & Co. (LLY) | 0.9 | $29M | 350k | 83.49 | |
Regeneron Pharmaceuticals (REGN) | 0.9 | $28M | 54k | 510.12 | |
Atara Biotherapeutics | 0.8 | $26M | 501k | 52.76 | |
Tg Therapeutics (TGTX) | 0.8 | $26M | 1.5M | 16.59 | |
Liberty Broadband Corp Com Ser A (LBRDA) | 0.6 | $18M | 346k | 50.97 | |
Alps Etf Tr Alerian Mlp Call Option | 0.5 | $16M | 1.0M | 15.56 | |
Dyax | 0.4 | $14M | 523k | 26.50 | |
Cameco Corporation (CCJ) | 0.4 | $12M | 814k | 14.28 | |
Albany Molecular Research | 0.4 | $11M | 559k | 20.22 | |
Synergy Pharmaceuticals Del Com New | 0.2 | $7.0M | 847k | 8.30 | |
Black Knight Finl Svcs Cl A | 0.2 | $6.7M | 216k | 30.87 | |
Lexicon Pharmaceuticals Com New (LXRX) | 0.1 | $2.1M | 260k | 8.05 | |
Response Genetics (RGDXQ) | 0.1 | $2.0M | 6.0M | 0.33 | |
Nivalis Therapeutics | 0.0 | $452k | 33k | 13.63 |